AGP Executive Report
Last update: 8 hours agoRegulatory & Public Health Tech: India rolled out Air Suvidha 2.0 for contactless health self-declarations for travelers from Ebola-affected countries, aiming to speed screening and data sharing at entry points. Oncology Drug Updates: The FDA expanded Gilead’s Trodelvy as a first-line option for triple-negative breast cancer, intensifying competition in early treatment settings. Rare Disease & Precision Care: A new market outlook projects rare neurological disease treatments could nearly double to $43.7B by 2036 as orphan approvals and genetic diagnostics expand access. Healthcare AI Readiness: A Nutanix survey warns healthcare AI adoption is outpacing infrastructure readiness, with “shadow AI” growing while governance and secure bedside support lag. Women’s Health: U.N.-cited research highlights persistent underdiagnosis and mistreatment of women’s health concerns, with mental health disparities especially for LGBTQ+ people. Clinical Care Innovation: Ruby Hall Clinic launched a pelvic floor rehabilitation program using electromagnetic stimulation and automated Kegel training for incontinence and related disorders. Pharma Manufacturing Policy: AiMeD praised Haryana’s 2026 pharma and medical devices manufacturing policy for incentives aimed at boosting investment, jobs, and exports. Patient Safety Reminder: Experts urged hydration for people on GLP-1 weight-loss drugs during extreme heat, warning not to wait for thirst.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
